SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
28-Apr-21 7:31 PM View: | Revolution Medicines, Inc. (RVMD) | 28-Apr-21 | Market Sale (Planned) | 100 | $42.50 | $4,250.00 | (< 1%) 4.74M to 4.74M | (< 1%) |
28-Apr-21 7:31 PM View: | Revolution Medicines, Inc. (RVMD) | 27-Apr-21 | Market Sale (Planned) | 23,326 | $42.65 | $994,922.00 | (< 1%) 4.76M to 4.74M | (< 1%) |
28-Apr-21 7:31 PM View: | Revolution Medicines, Inc. (RVMD) | 26-Apr-21 | Market Sale (Planned) | 52,984 | $42.85 | $2,270,170.00 | (1%) 4.81M to 4.76M | < 1% |
12-Apr-21 5:41 PM View: | Revolution Medicines, Inc. (RVMD) | 09-Apr-21 | Market Sale (Planned) | 24,701 | $43.83 | $1,082,540.00 | (< 1%) 4.84M to 4.81M | 3% |
12-Apr-21 5:41 PM View: | Revolution Medicines, Inc. (RVMD) | 08-Apr-21 | Market Sale (Planned) | 46,228 | $44.80 | $2,071,200.00 | (< 1%) 4.88M to 4.84M | 5% |
07-Apr-21 6:23 PM View: | Revolution Medicines, Inc. (RVMD) | 07-Apr-21 | Market Sale (Planned) | 27,953 | $45.60 | $1,274,780.00 | (< 1%) 4.91M to 4.88M | (4%) |
07-Apr-21 6:23 PM View: | Revolution Medicines, Inc. (RVMD) | 06-Apr-21 | Market Sale (Planned) | 39,500 | $48.06 | $1,898,440.00 | (< 1%) 4.95M to 4.91M | 1% |
07-Apr-21 6:23 PM View: | Revolution Medicines, Inc. (RVMD) | 05-Apr-21 | Market Sale (Planned) | 18,215 | $46.65 | $849,817.00 | (< 1%) 4.97M to 4.95M | (2%) |
11-Dec-20 6:39 PM View: | Revolution Medicines, Inc. (RVMD) | 09-Dec-20 | Acquisition (other) | 46,914 | -- | -- | < 1% 5.96M to 6.0M | |
11-Dec-20 6:39 PM View: | Revolution Medicines, Inc. (RVMD) | 09-Dec-20 | Acquisition (other) | 13,068 | -- | -- | < 1% 6.0M to 6.02M | |
11-Dec-20 6:39 PM View: | Revolution Medicines, Inc. (RVMD) | 09-Dec-20 | Disposition (other) | 1,046,870 | -- | -- | (17%) 6.02M to 4.97M | |
18-Nov-20 6:58 PM View: | Revolution Medicines, Inc. (RVMD) | 16-Nov-20 | Sale | 2,027,160 | $36.40 | $73,788,496.00 | (25%) 7.98M to 5.96M | |
22-Sep-20 7:51 PM View: | Rapt Therapeutics, Inc. (RAPT) | 22-Sep-20 | Sale Duplicate | 608,000 | $30.85 | $18,756,800.00 | (10%) 6.24M to 5.63M | |
19-Aug-20 5:41 PM View: | Rapt Therapeutics, Inc. (RAPT) | 17-Aug-20 | Sale Duplicate | 538,654 | $22.75 | $12,254,400.00 | (8%) 6.78M to 6.24M | |
19-Jun-20 3:34 PM View: | Revolution Medicines, Inc. (RVMD) | 17-Jun-20 | Grant | 7,234 | -- | -- | < 1% 7.98M to 7.98M | |
28-Apr-20 5:10 PM View: | Oric Pharmaceuticals, Inc. (ORIC) | 28-Apr-20 | Conversion Duplicate | 4,693,180 | -- | -- | 6258% 75.0K to 4.77M | |
09-Apr-20 5:56 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 08-Apr-20 | Market Purchase Duplicate | 112,602 | $14.95 | $1,683,400.00 | < 1% 17.61M to 17.73M | 109% |
07-Apr-20 7:28 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 07-Apr-20 | Market Purchase Duplicate | 123,728 | $14.38 | $1,779,210.00 | < 1% 17.49M to 17.61M | 117% |
07-Apr-20 7:28 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 03-Apr-20 | Market Purchase Duplicate | 14,587 | $12.41 | $181,025.00 | < 1% 17.48M to 17.49M | 152% |
02-Apr-20 6:16 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 02-Apr-20 | Market Purchase Duplicate | 14,850 | $12.40 | $184,140.00 | < 1% 17.46M to 17.48M | 152% |
02-Apr-20 6:16 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 01-Apr-20 | Market Purchase Duplicate | 118,067 | $12.26 | $1,447,500.00 | < 1% 17.34M to 17.46M | 155% |
02-Apr-20 6:16 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 31-Mar-20 | Market Purchase Duplicate | 118,067 | $12.53 | $1,479,380.00 | < 1% 17.23M to 17.34M | 149% |
25-Mar-20 7:45 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 25-Mar-20 | Market Purchase Duplicate | 2,416 | $12.49 | $30,175.80 | < 1% 17.22M to 17.23M | 150% |
25-Mar-20 7:45 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 24-Mar-20 | Market Purchase Duplicate | 128,377 | $12.22 | $1,568,770.00 | < 1% 17.09M to 17.22M | 156% |
25-Mar-20 7:45 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 23-Mar-20 | Market Purchase Duplicate | 170,387 | $11.63 | $1,981,600.00 | 1% 16.92M to 17.09M | 169% |
23-Mar-20 5:09 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 20-Mar-20 | Market Purchase Duplicate | 143,082 | $11.77 | $1,684,080.00 | < 1% 16.78M to 16.92M | 165% |
23-Mar-20 5:09 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 19-Mar-20 | Market Purchase Duplicate | 148,464 | $11.59 | $1,720,700.00 | < 1% 16.63M to 16.78M | 169% |
06-Mar-20 5:59 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 05-Mar-20 | Market Purchase Duplicate | 8,307 | $18.00 | $149,526.00 | < 1% 16.62M to 16.63M | 73% |
04-Mar-20 7:26 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 04-Mar-20 | Market Purchase Duplicate | 9,986 | $17.96 | $179,349.00 | < 1% 16.61M to 16.62M | 74% |
04-Mar-20 7:26 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 03-Mar-20 | Market Purchase Duplicate | 38,758 | $17.99 | $697,256.00 | < 1% 16.58M to 16.61M | 74% |
04-Mar-20 7:26 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 02-Mar-20 | Market Purchase Duplicate | 14,124 | $17.90 | $252,820.00 | < 1% 16.56M to 16.58M | 74% |
28-Feb-20 7:09 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 28-Feb-20 | Market Purchase Duplicate | 37,800 | $17.91 | $676,998.00 | < 1% 16.52M to 16.56M | 74% |
28-Feb-20 7:09 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 27-Feb-20 | Market Purchase Duplicate | 33,896 | $17.91 | $607,077.00 | < 1% 16.49M to 16.52M | 74% |
28-Feb-20 7:09 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 26-Feb-20 | Market Purchase Duplicate | 3,751 | $18.00 | $67,518.00 | < 1% 16.49M to 16.49M | 73% |
10-Feb-20 4:47 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 06-Feb-20 | Market Purchase Duplicate | 44,900 | $15.96 | $716,604.00 | < 1% 16.44M to 16.49M | 96% |
13-Nov-19 5:35 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 11-Nov-19 | Market Purchase Duplicate | 15 | $12.00 | $180.00 | < 1% 16.44M to 16.44M | 160% |
06-Nov-19 5:55 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 04-Nov-19 | Market Purchase Duplicate | 8,409 | $11.99 | $100,824.00 | < 1% 16.43M to 16.44M | 161% |
24-Oct-19 7:29 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 23-Oct-19 | Market Purchase Duplicate | 2,087 | $11.86 | $24,751.80 | < 1% 16.43M to 16.43M | 163% |
24-Oct-19 7:29 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 22-Oct-19 | Market Purchase Duplicate | 2,300 | $12.00 | $27,600.00 | < 1% 16.43M to 16.43M | 160% |
21-Oct-19 7:29 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 21-Oct-19 | Market Purchase Duplicate | 43,400 | $11.94 | $518,196.00 | < 1% 16.38M to 16.43M | 162% |
21-Oct-19 7:29 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 18-Oct-19 | Market Purchase Duplicate | 34,721 | $11.29 | $392,000.00 | < 1% 16.35M to 16.38M | 177% |
21-Oct-19 7:29 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 17-Oct-19 | Market Purchase Duplicate | 6,818 | $10.62 | $72,407.20 | < 1% 16.34M to 16.35M | 194% |
16-Oct-19 8:22 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 16-Oct-19 | Market Purchase Duplicate | 34,900 | $10.26 | $358,074.00 | < 1% 16.31M to 16.34M | 204% |
16-Oct-19 8:22 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 15-Oct-19 | Market Purchase Duplicate | 33,200 | $10.31 | $342,292.00 | < 1% 16.27M to 16.31M | 203% |
16-Oct-19 8:22 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 14-Oct-19 | Market Purchase Duplicate | 34,900 | $10.36 | $361,564.00 | < 1% 16.24M to 16.27M | 202% |
11-Oct-19 8:31 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 11-Oct-19 | Market Purchase Duplicate | 17,724 | $10.57 | $187,343.00 | < 1% 16.22M to 16.24M | 196% |
11-Oct-19 8:31 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 10-Oct-19 | Market Purchase Duplicate | 17,724 | $10.50 | $186,102.00 | < 1% 16.2M to 16.22M | 198% |
11-Oct-19 8:31 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 09-Oct-19 | Market Purchase Duplicate | 17,724 | $10.26 | $181,848.00 | < 1% 16.19M to 16.2M | 204% |
09-Aug-19 7:48 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 09-Aug-19 | Market Purchase Duplicate | 152 | $13.99 | $2,126.48 | < 1% 16.19M to 16.19M | 123% |
09-Aug-19 7:48 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 08-Aug-19 | Market Purchase Duplicate | 12 | $13.98 | $167.76 | < 1% 16.19M to 16.19M | 124% |